Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
62
HSIC Quote, Financials, Valuation and Earnings
Last price:
$76.25
Seasonality move
:
4.67%
Day range:
$75.85 - $76.78
52-week range:
$60.56 - $82.49
Dividend yield:
0%
P/E ratio:
24.07x
P/S ratio:
0.73x
P/B ratio:
2.67x
Volume:
510.5K
Avg. volume:
1.3M
1-year change:
8.83%
Market cap:
$9B
Revenue:
$12.7B
EPS (TTM):
$3.17
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HSIC
Henry Schein, Inc.
|
$3.3B | $1.28 | 4.9% | 73.2% | $77.64 |
|
ADGM
Adagio Medical Holdings, Inc.
|
-- | -$0.24 | -100% | -91.79% | $4.00 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$17.8M | -$0.08 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano, Inc.
|
$3.4M | -$7.10 | 76.06% | -41.21% | $30.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HSIC
Henry Schein, Inc.
|
$76.19 | $77.64 | $9B | 24.07x | $0.00 | 0% | 0.73x |
|
ADGM
Adagio Medical Holdings, Inc.
|
$1.06 | $4.00 | $22.3M | 218.00x | $0.00 | 0% | 118.08x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$4.98 | -- | $4.8M | -- | $0.00 | 0% | 9.90x |
|
LAB
Standard BioTools, Inc.
|
$1.47 | $1.65 | $565.3M | -- | $0.00 | 0% | 4.32x |
|
LNSR
LENSAR, Inc.
|
$12.01 | $15.00 | $143.5M | -- | $0.00 | 0% | 2.41x |
|
MOVE
Movano, Inc.
|
$7.97 | $30.00 | $6.7M | -- | $0.00 | 0% | 12.06x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HSIC
Henry Schein, Inc.
|
50.59% | 1.198 | 36.57% | 0.62x |
|
ADGM
Adagio Medical Holdings, Inc.
|
106.35% | 2.155 | 73.62% | 0.48x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.804 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.208 | 1.79% | 0.65x |
|
MOVE
Movano, Inc.
|
212.35% | 2.628 | 67.05% | 0.29x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HSIC
Henry Schein, Inc.
|
$958M | $206M | 5.12% | 8.47% | 6.17% | $129M |
|
ADGM
Adagio Medical Holdings, Inc.
|
-$531K | -$5.7M | -193.23% | -340.49% | -- | -$3.5M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
MOVE
Movano, Inc.
|
-$200K | -$2.6M | -337.24% | -410.28% | -3238.75% | -$1.6M |
Henry Schein, Inc. vs. Competitors
-
Which has Higher Returns HSIC or ADGM?
Adagio Medical Holdings, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of --. Henry Schein, Inc.'s return on equity of 8.47% beat Adagio Medical Holdings, Inc.'s return on equity of -340.49%.
Company Gross Margin Earnings Per Share Invested Capital HSICHenry Schein, Inc.28.69% $0.83 $8.3B ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M -
What do Analysts Say About HSIC or ADGM?
Henry Schein, Inc. has a consensus price target of $77.64, signalling upside risk potential of 1.91%. On the other hand Adagio Medical Holdings, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 300%. Given that Adagio Medical Holdings, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than Henry Schein, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HSICHenry Schein, Inc.2 9 1 ADGMAdagio Medical Holdings, Inc.1 0 0 -
Is HSIC or ADGM More Risky?
Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Adagio Medical Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HSIC or ADGM?
Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Adagio Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Adagio Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HSIC or ADGM?
Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Adagio Medical Holdings, Inc. quarterly revenues of --. Henry Schein, Inc.'s net income of $109M is higher than Adagio Medical Holdings, Inc.'s net income of -$10.1M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 24.07x while Adagio Medical Holdings, Inc.'s PE ratio is 218.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.73x versus 118.08x for Adagio Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HSICHenry Schein, Inc.0.73x 24.07x $3.3B $109M ADGMAdagio Medical Holdings, Inc.118.08x 218.00x -- -$10.1M
-
Which has Higher Returns HSIC or INBS?
Intelligent Bio Solutions, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -269.38%. Henry Schein, Inc.'s return on equity of 8.47% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital HSICHenry Schein, Inc.28.69% $0.83 $8.3B INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About HSIC or INBS?
Henry Schein, Inc. has a consensus price target of $77.64, signalling upside risk potential of 1.91%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 2309.64%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Henry Schein, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HSICHenry Schein, Inc.2 9 1 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is HSIC or INBS More Risky?
Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HSIC or INBS?
Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HSIC or INBS?
Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Henry Schein, Inc.'s net income of $109M is higher than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 24.07x while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.73x versus 9.90x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HSICHenry Schein, Inc.0.73x 24.07x $3.3B $109M INBSIntelligent Bio Solutions, Inc.9.90x -- $1.1M -$3M
-
Which has Higher Returns HSIC or LAB?
Standard BioTools, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -162.05%. Henry Schein, Inc.'s return on equity of 8.47% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital HSICHenry Schein, Inc.28.69% $0.83 $8.3B LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About HSIC or LAB?
Henry Schein, Inc. has a consensus price target of $77.64, signalling upside risk potential of 1.91%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 5.44%. Given that Standard BioTools, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Standard BioTools, Inc. is more attractive than Henry Schein, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HSICHenry Schein, Inc.2 9 1 LABStandard BioTools, Inc.1 2 0 -
Is HSIC or LAB More Risky?
Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock HSIC or LAB?
Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HSIC or LAB?
Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Standard BioTools, Inc. quarterly revenues of $19.6M. Henry Schein, Inc.'s net income of $109M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 24.07x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.73x versus 4.32x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HSICHenry Schein, Inc.0.73x 24.07x $3.3B $109M LABStandard BioTools, Inc.4.32x -- $19.6M -$31.7M
-
Which has Higher Returns HSIC or LNSR?
LENSAR, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -25.94%. Henry Schein, Inc.'s return on equity of 8.47% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital HSICHenry Schein, Inc.28.69% $0.83 $8.3B LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About HSIC or LNSR?
Henry Schein, Inc. has a consensus price target of $77.64, signalling upside risk potential of 1.91%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.9%. Given that LENSAR, Inc. has higher upside potential than Henry Schein, Inc., analysts believe LENSAR, Inc. is more attractive than Henry Schein, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HSICHenry Schein, Inc.2 9 1 LNSRLENSAR, Inc.0 2 0 -
Is HSIC or LNSR More Risky?
Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.
-
Which is a Better Dividend Stock HSIC or LNSR?
Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HSIC or LNSR?
Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than LENSAR, Inc. quarterly revenues of $14.3M. Henry Schein, Inc.'s net income of $109M is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 24.07x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.73x versus 2.41x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HSICHenry Schein, Inc.0.73x 24.07x $3.3B $109M LNSRLENSAR, Inc.2.41x -- $14.3M -$3.7M
-
Which has Higher Returns HSIC or MOVE?
Movano, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -5036.25%. Henry Schein, Inc.'s return on equity of 8.47% beat Movano, Inc.'s return on equity of -410.28%.
Company Gross Margin Earnings Per Share Invested Capital HSICHenry Schein, Inc.28.69% $0.83 $8.3B MOVEMovano, Inc.-250% -$4.73 $1.5M -
What do Analysts Say About HSIC or MOVE?
Henry Schein, Inc. has a consensus price target of $77.64, signalling upside risk potential of 1.91%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3664.12%. Given that Movano, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Movano, Inc. is more attractive than Henry Schein, Inc..
Company Buy Ratings Hold Ratings Sell Ratings HSICHenry Schein, Inc.2 9 1 MOVEMovano, Inc.0 0 0 -
Is HSIC or MOVE More Risky?
Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HSIC or MOVE?
Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HSIC or MOVE?
Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Movano, Inc. quarterly revenues of $80K. Henry Schein, Inc.'s net income of $109M is higher than Movano, Inc.'s net income of -$4M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 24.07x while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.73x versus 12.06x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HSICHenry Schein, Inc.0.73x 24.07x $3.3B $109M MOVEMovano, Inc.12.06x -- $80K -$4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
